SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001354488-14-000360
Filing Date
2014-01-28
Accepted
2014-01-28 17:00:52
Documents
14

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT oxbt_424b3.htm 424B3 636046
2 oxygenbio.jpg GRAPHIC 7795
3 ex99201.jpg GRAPHIC 48753
4 ex99202.jpg GRAPHIC 73668
5 ex99203.jpg GRAPHIC 225896
6 ex99204.jpg GRAPHIC 104008
7 ex99205.jpg GRAPHIC 77336
8 ex99206.jpg GRAPHIC 81150
9 ex99207.jpg GRAPHIC 81628
10 ex99208.jpg GRAPHIC 92316
11 ex99209.jpg GRAPHIC 302798
12 ex99210.jpg GRAPHIC 255220
13 ex99211.jpg GRAPHIC 194397
14 ex99301.jpg GRAPHIC 7621
  Complete submission text file 0001354488-14-000360.txt   2778005
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B3 | Act: 33 | File No.: 333-187466 | Film No.: 14553689
SIC: 8731 Services-Commercial Physical & Biological Research